Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5133)
American Well Corp (AMWL)
McNeice Paul Francis — Chief Accounting Officer
Shares
112
Price
$9.74
Total Value
$1.09K
Shares Held After
10,504
% of Holdings
1.1%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
301
Price
$50.26
Total Value
$15.13K
Shares Held After
158,494
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,949
Price
$49.40
Total Value
$96.29K
Shares Held After
158,795
% of Holdings
1.2%
American Well Corp (AMWL)
HIRSCHHORN MARK — Chief Financial Officer
Shares
10,761
Price
$9.74
Total Value
$104.81K
Shares Held After
243,238
% of Holdings
4.2%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
553
Price
$26.24
Total Value
$14.51K
Shares Held After
27,970
% of Holdings
1.9%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
6,090
Price
$26.20
Total Value
$159.54K
Shares Held After
344,897
% of Holdings
1.7%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
250
Price
$49.40
Total Value
$12.35K
Shares Held After
31,464
% of Holdings
0.8%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
276
Price
$60.87
Total Value
$16.80K
Shares Held After
146,743
% of Holdings
0.2%
AVITA Medical, Inc. (RCEL)
Woody Joseph Fralin — Director
Shares
5,000
Price
$4.26
Total Value
$21.30K
Shares Held After
10,000
% of Holdings
50.0%
AVITA Medical, Inc. (RCEL)
Woody Joseph Fralin — Director
Shares
5,000
Price
$4.34
Total Value
$21.70K
Shares Held After
5,000
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
85,533
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
279
Price
$101.79
Total Value
$28.40K
Shares Held After
85,733
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,588
Price
$100.65
Total Value
$260.48K
Shares Held After
86,012
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,133
Price
$99.86
Total Value
$312.86K
Shares Held After
88,600
% of Holdings
3.4%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,200
Price
$98.57
Total Value
$118.28K
Shares Held After
91,733
% of Holdings
1.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
900
Price
$97.68
Total Value
$87.91K
Shares Held After
92,933
% of Holdings
1.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,170
Price
$95.99
Total Value
$208.30K
Shares Held After
93,833
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
960
Price
$94.87
Total Value
$91.08K
Shares Held After
96,003
% of Holdings
1.0%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
15,000
Price
$60.22
Total Value
$903.30K
Shares Held After
15,000
% of Holdings
50.0%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
2,746,332
Price
$0.14
Total Value
$378.99K
Shares Held After
351,959
% of Holdings
780.3%
BECTON DICKINSON & CO (BDX)
Polen Thomas E Jr — Director
Shares
2,764
Price
$146.35
Total Value
$404.51K
Shares Held After
110,163
% of Holdings
2.4%
MCKESSON CORP (MCK)
Rodgers Thomas L — EVP, Chief Strategy & BDO
Shares
123
Price
$735.50
Total Value
$90.47K
Shares Held After
2,967
% of Holdings
4.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
99
Price
$15.34
Total Value
$1.52K
Shares Held After
12,838,101
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
343,521
Price
$15.28
Total Value
$5.25M
Shares Held After
12,838,002
% of Holdings
2.7%
GENELUX Corp (GNLX)
Thomas John — Director
Shares
10,000
Price
$2.98
Total Value
$29.80K
Shares Held After
472,784
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
3,977
Price
$100.00
Total Value
$397.70K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
883
Price
$99.66
Total Value
$88.00K
Shares Held After
194,309
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,021
Price
$98.20
Total Value
$100.26K
Shares Held After
195,192
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,973
Price
$97.56
Total Value
$192.49K
Shares Held After
196,213
% of Holdings
1.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,926
Price
$96.15
Total Value
$665.93K
Shares Held After
198,186
% of Holdings
3.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
16,595
Price
$95.34
Total Value
$1.58M
Shares Held After
205,112
% of Holdings
7.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,602
Price
$94.64
Total Value
$246.25K
Shares Held After
221,707
% of Holdings
1.2%
QTREX Quantum Ltd. (QTEX)
Tehila Yafit — Chief Financial Officer
Shares
28,100
Price
$3.50
Total Value
$98.35K
Shares Held After
870,000
% of Holdings
3.1%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
9,747
Price
$9.62
Total Value
$93.77K
Shares Held After
130,079
% of Holdings
7.0%
QUEST DIAGNOSTICS INC (DGX)
Davis J. E. — Director
Shares
10,000
Price
$194.14
Total Value
$1.94M
Shares Held After
132,423
% of Holdings
7.0%
Simulations Plus, Inc. (SLP)
WOLTOSZ WALTER S — Director
Shares
15,000
Price
$17.43
Total Value
$261.45K
Shares Held After
3,252,800
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
12,837
Price
$69.74
Total Value
$895.25K
Shares Held After
2,565,489
% of Holdings
0.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
468
Price
$19.73
Total Value
$9.23K
Shares Held After
594,538
% of Holdings
0.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
4,998
Price
$19.41
Total Value
$97.02K
Shares Held After
595,006
% of Holdings
0.8%
NovaBridge Biosciences (NBP)
Xu Cong Claire — SVP, Clinical Development
Shares
3,494
Price
$3.94
Total Value
$13.77K
Shares Held After
290,154
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
4,159
Price
$91.37
Total Value
$380.01K
Shares Held After
4,000
% of Holdings
51.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
16,943
Price
$90.72
Total Value
$1.54M
Shares Held After
8,159
% of Holdings
67.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
5,428
Price
$89.72
Total Value
$487.00K
Shares Held After
25,102
% of Holdings
17.8%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
6,000
Price
$230.30
Total Value
$1.38M
Shares Held After
35,140
% of Holdings
14.6%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$6.06
Total Value
$100.98K
Shares Held After
1,176,506
% of Holdings
1.4%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
1,038
Price
$132.97
Total Value
$138.02K
Shares Held After
617,567
% of Holdings
0.2%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
3,062
Price
$132.22
Total Value
$404.84K
Shares Held After
618,605
% of Holdings
0.5%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
10,900
Price
$131.10
Total Value
$1.43M
Shares Held After
621,667
% of Holdings
1.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
200
Price
$230.41
Total Value
$46.08K
Shares Held After
41,382
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,216
Price
$229.47
Total Value
$279.03K
Shares Held After
41,582
% of Holdings
2.8%
Showing 351–400 of 5133 transactions (page 8 of 103)